Patent US4812461A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4812461A Expired / Lapsed US ⏱️ 0.0 years remaining

Imide derivatives and their use in the treatment psychosis

Assignee: Sumitomo Pharma Co Ltd
•
Filing: 1987-09-25
•
Granted: 1989-03-14
•
Expires: 2007-09-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An imide derivative of the formula: <CHEM> or its salt, useful as an antipsychotic drug.

Inventors

  • 👤 Fujio Antoku
  • 👤 Mayumi Yoshigi
  • 👤 Ikutaro Saji
  • 👤 Atsuyuki Kojima
  • 👤 Kukuo Ishizumi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 16:31
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/06; A; A61; A61P; A61P25/00; A61P25/18; C07D211/00; C07D211/04; C07D211/80; C07D211/84; C07D211/86; C07D211/88; C07D417/00; C07D417/02; C07D417/06; C07D417/14

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 353 words
A compound of the formula: ##STR187## wherein A is a carbonyl group or a sulfonyl group; B is either one of the following formulas: ##STR188## wherein R 1 and R 2 are each a hydrogen atom, or either one of R 1 and R 2 is a hydrogen atom and the other is a hydroxyl group, a lower alkyl group or a lower alkanoyloxy group, or R 1 and R 2 are combined together to represent an oxo group, E is a methylene group, an ethylene group or an oxygen atom and a full line accompanying a broken line ( ) indicates a single bond or a double bond, ##STR189## wherein F is a methylene group or an ethylene group and R 1 , R 2 and a full line accompanying a broken line ( ) are each as defined above, ##STR190## wherein R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each a hydrogen atom or a lower alkyl group and R 1 , R 2 and a full line accompanying a broken line ( ) are each as defined above, ##STR191## wherein R 9 and R 10 are each a lower alkyl group, or B is a 1,2-phenylene group when A represents a sulfonyl group; W is a lower alkylene group, a lower alkenylene group, a lower alkynylene group or a lower alkylene group substituted with hydroxyl; and G is a benzoisothiazolyl group, a benzoiosthiazolyl substituted with a member selected from the group consisting of lower alkyl, lower alkoxy, halogen, and halogenated lower alkyl, or a group of the formula: ##STR192## wherein Y is an oxygen atom, a carbonyl group, a methylene group, a group of the formula: ##STR193## wherein m is an integer of 0, 1 or 2, a group of the formula: ##STR194## wherein R 13 is a hydrogen atom, a lower alkyl group or a lower alkanoyl group or a group of the formula: ##STR195## and Z is a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 353 words
A compound of the formula: ##STR187## wherein A is a carbonyl group or a sulfonyl group; B is either one of the following formulas: ##STR188## wherein R 1 and R 2 are each a hydrogen atom, or either one of R 1 and R 2 is a hydrogen atom and the other is a hydroxyl group, a lower alkyl group or a lower alkanoyloxy group, or R 1 and R 2 are combined together to represent an oxo group, E is a methylene group, an ethylene group or an oxygen atom and a full line accompanying a broken line ( ) indicates a single bond or a double bond, ##STR189## wherein F is a methylene group or an ethylene group and R 1 , R 2 and a full line accompanying a broken line ( ) are each as defined above, ##STR190## wherein R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each a hydrogen atom or a lower alkyl group and R 1 , R 2 and a full line accompanying a broken line ( ) are each as defined above, ##STR191## wherein R 9 and R 10 are each a lower alkyl group, or B is a 1,2-phenylene group when A represents a sulfonyl group; W is a lower alkylene group, a lower alkenylene group, a lower alkynylene group or a lower alkylene group substituted with hydroxyl; and G is a benzoisothiazolyl group, a benzoiosthiazolyl substituted with a member selected from the group consisting of lower alkyl, lower alkoxy, halogen, and halogenated lower alkyl, or a group of the formula: ##STR192## wherein Y is an oxygen atom, a carbonyl group, a methylene group, a group of the formula: ##STR193## wherein m is an integer of 0, 1 or 2, a group of the formula: ##STR194## wherein R 13 is a hydrogen atom, a lower alkyl group or a lower alkanoyl group or a group of the formula: ##STR195## and Z is a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 52 words
The compound according to claim 1, wherein A is a carbonyl group and B is a group of the formula: ##STR196## wherein F is a methylene group or an ethylene group and R 1 , R 2 and a full line accompanying a broken line ( ) are each as defined above.
Claim 4
Dependent Claim 33 words
The compound according to claim 1, wherein A is a carbonyl group and B is a group of the formula: ##STR197## wherein R 9 and R 10 are each a lower alkyl group.
Claim 5
Dependent Claim 18 words
The compound according to claim 1, wherein A is a sulfonyl group and B is a 1,2-phenylene group.
Claim 6
Dependent Claim 58 words
The compound according to claim 1, wherein W is a tetramethylene group or either one of the following groups: --CH 2 CH═CHCH 2 --, --CH 2 C.tbd.CCH 2 --, --CH 2 CH(OH)CH 2 CH 2 -- and --CH 2 CH 2 CH(OH)CH 2 -- and G is a substituted benzoyl group or a substituted or unsubstituted benzoisothiazolyl group.
Claim 7
Dependent Claim 297 words
A compound of the formula: ##STR198## wherein A is a carbonyl group or a sulfonyl group; B is either one of the following formulas: ##STR199## wherein R 1 and R 2 are each a hydrogen atom, or either one of R 1 and R 2 is a hydrogen atom and the other is a hydroxyl group, a lower alkyl group, or a lower alkanoyloxy group, or R 1 and R 2 are combined together to represent an oxo group, E is a methylene group, an ethylene group or an oxygen atom and a full line accompanying a broken line ( ) indicates a single bond or a double bond; ##STR200## wherein R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each a hydrogen atom or a lower alkyl group and R 1 , R 2 , and a full line accompanying a broken line ( ) are each as defined above; W is a lower alkylene group, a lower alkenylene group, a lower alkynylene group or a lower alkylene group substituted with hydroxyl; and G is a benzoisothiazolyl group, a benzoiosthiazolyl substituted with a member selected from the group consisting of lower alkyl, lower alkoxy, halogen, and halogenated lower alkyl, or a group of the formula: ##STR201## wherein Y is an oxygen atom, a carbonyl group, a methylene group, a group of the formula: ##STR202## wherein m is an integer of 0, 1 or 2, a group of the formula: ##STR203## wherein R 13 is a hydrogen atom, a lower alkyl group or a lower alkanoyl group or a group of the formula: ##STR204## and Z is a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group, or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim 297 words
A compound of the formula: ##STR198## wherein A is a carbonyl group or a sulfonyl group; B is either one of the following formulas: ##STR199## wherein R 1 and R 2 are each a hydrogen atom, or either one of R 1 and R 2 is a hydrogen atom and the other is a hydroxyl group, a lower alkyl group, or a lower alkanoyloxy group, or R 1 and R 2 are combined together to represent an oxo group, E is a methylene group, an ethylene group or an oxygen atom and a full line accompanying a broken line ( ) indicates a single bond or a double bond; ##STR200## wherein R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each a hydrogen atom or a lower alkyl group and R 1 , R 2 , and a full line accompanying a broken line ( ) are each as defined above; W is a lower alkylene group, a lower alkenylene group, a lower alkynylene group or a lower alkylene group substituted with hydroxyl; and G is a benzoisothiazolyl group, a benzoiosthiazolyl substituted with a member selected from the group consisting of lower alkyl, lower alkoxy, halogen, and halogenated lower alkyl, or a group of the formula: ##STR201## wherein Y is an oxygen atom, a carbonyl group, a methylene group, a group of the formula: ##STR202## wherein m is an integer of 0, 1 or 2, a group of the formula: ##STR203## wherein R 13 is a hydrogen atom, a lower alkyl group or a lower alkanoyl group or a group of the formula: ##STR204## and Z is a hydrogen atom, a halogen atom, a lower alkyl group or a lower alkoxy group, or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 58 words
The compound according to claim 6, wherein W is a tetramethylene group or either one of the following groups: --CH 2 CH═CHCH 2 --, --CH 2 C═CCH 2 --, --CH 2 CH(OH)CH 2 CH 2 -- and --CH 2 CH 2 CH(OH)CH 2 -- and G is a substituted benzoyl group or a substituted or unsubstituted benzoisothiazolyl group.
Claim 10
Dependent Claim 46 words
The compound according to claim 6, wherein said pharmaceutically acceptable salt is a salt of a member selected from the group consisting of hydrochloric acid, hydrobromic acid, hydroiodic acid, sulfuric acid, acetic acid, oxalic acid, citric acid, maleic acid, tartaric acid, fumaric acid, and maleic acid.
Claim 11
Dependent Claim 104 words
The compound according to claim 6, wherein A is a carbonyl group and B is a group of the formula: ##STR205## wherein R 1 and R 2 are each a hydrogen atom, or one of R 1 and R 2 is a hydrogen atom and the other is a hydroxyl group, a lower alkyl group or a lower alkanoyloxy group, or R 1 and R 2 are combined together to represent an oxo group, E is a methylene group, an ethylene group or an oxygen atom and a full line accompanying a broken line ( ) indicates a single bond or a double bond.
Claim 12
Dependent Claim 70 words
The compound according to claim 6, wherein A is a carbonyl group and B is a group of the formula: ##STR206## wherein R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are each a hydrogen atom or a lower alkyl group and R 1 , R 2 and a full line accompanying a broken line ( ) are each as defined above.
Claim 13
Dependent Claim 39 words
The compound according to claim 6, which is represented by the formula: ##STR207## wherein E is a methylene group or an ethylene group and a full line accompanying a broken line ( ) is as defined in claim 1.
Claim 14
Dependent Claim 29 words
The compound according to claim 6, which is represented by the formula: ##STR208## wherein a full line accompanying a broken line ( ) is as defined in claim 1.
Claim 15
Dependent Claim 38 words
The compound according to claim 6, which is by the formula: ##STR209## wherein E is a methylene group or an ethylene group and a full line accompanying a broken line ( ) is as defined in claim 1.
Claim 16
Dependent Claim 29 words
The compound according to claim 6, which is represented by the formula: ##STR210## wherein a full line accompanying a broken line ( ) is as defined in claim 1.
Claim 17
Dependent Claim 37 words
A pharmaceutical composition for treatment of psychosis which comprises as an active ingredient a pharmaceutically effective amount of at least one compound as claimed in claim 1, and at least one pharmaceutically acceptable inert carrier or diluent.
Claim 18
Dependent Claim 26 words
A method for treatment of psychosis which comprises administering to a person a pharmaceutically effective amount of at least one compound as claimed in claim 1.
Claim 19
Dependent Claim 37 words
A pharmaceutical composition for treatment of psychosis which comprises as an active ingredient a pharmaceutically effective amount of at least one compound as claimed in claim 6, and at least one pharmaceutically acceptable inert carrier or diluent.
Claim 20
Dependent Claim 26 words
A method for treatment of psychosis which comprises administering to a person a pharmaceutically effective amount of at least one compound as claimed in claim 6.

References Cited (Backward Citations)

US3398151A Cited
US3717634A Cited
US4479954A Cited
US4507303A Cited
US4543355A Cited
US4411901A Cited
US4598078A Cited
US4567180A Cited
US4524206A Cited
US4562255A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-03-13 1992-09-12 1993-03-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-03-13 1996-09-12 1997-03-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-03-13 2000-09-12 2001-03-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag